Works in Pharmaceuticals (14248247), 2023, Vol 16, Issue 6
Results: 131
Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 907, doi. 10.3390/ph16060907
- By:
- Publication type:
- Article
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 906, doi. 10.3390/ph16060906
- By:
- Publication type:
- Article
Lycopene from Red Guava (Psidium guajava L.): From Hepatoprotective Effect to Its Use as Promising Self-Emulsifying Drug Delivery System for Anti-Inflammatory and Antioxidant Applications.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 905, doi. 10.3390/ph16060905
- By:
- Publication type:
- Article
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 904, doi. 10.3390/ph16060904
- By:
- Publication type:
- Article
A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human Tissues.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 903, doi. 10.3390/ph16060903
- By:
- Publication type:
- Article
Asiatic Acid Inhibits Nasopharyngeal Carcinoma Cell Viability and Migration via Suppressing STAT3 and Claudin-1.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 902, doi. 10.3390/ph16060902
- By:
- Publication type:
- Article
Targeting Metalloenzymes: The "Achilles' Heel" of Viruses and Parasites.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 901, doi. 10.3390/ph16060901
- By:
- Publication type:
- Article
Relation of Statin Use with Esophageal Cancer.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 900, doi. 10.3390/ph16060900
- By:
- Publication type:
- Article
Nanotechnology-Aided Advancement in Combating the Cancer Metastasis.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 899, doi. 10.3390/ph16060899
- By:
- Publication type:
- Article
Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 898, doi. 10.3390/ph16060898
- By:
- Publication type:
- Article
Amantadine in Treatment of Dysthymia—The Pilot Case Series Study.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 897, doi. 10.3390/ph16060897
- By:
- Publication type:
- Article
Riluzole, a Derivative of Benzothiazole as a Potential Anti-Amoebic Agent against Entamoeba histolytica.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 896, doi. 10.3390/ph16060896
- By:
- Publication type:
- Article
Isolation, Purification, and Structural Characterization of Polysaccharides from Codonopsis pilosula and Their Anti-Tumor Bioactivity by Immunomodulation.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 895, doi. 10.3390/ph16060895
- By:
- Publication type:
- Article
Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 894, doi. 10.3390/ph16060894
- By:
- Publication type:
- Article
Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 893, doi. 10.3390/ph16060893
- By:
- Publication type:
- Article
Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 892, doi. 10.3390/ph16060892
- By:
- Publication type:
- Article
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 891, doi. 10.3390/ph16060891
- By:
- Publication type:
- Article
Inhibition of TRPA1, Endoplasmic Reticulum Stress, Human Airway Epithelial Cell Damage, and Ectopic MUC5AC Expression by Vasaka (Adhatoda vasica ; Malabar Nut) Tea.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 890, doi. 10.3390/ph16060890
- By:
- Publication type:
- Article
Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug–Gene Pairs to Know.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 889, doi. 10.3390/ph16060889
- By:
- Publication type:
- Article
Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 888, doi. 10.3390/ph16060888
- By:
- Publication type:
- Article
Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties †.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 887, doi. 10.3390/ph16060887
- By:
- Publication type:
- Article
Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 886, doi. 10.3390/ph16060886
- By:
- Publication type:
- Article
Hydrogen Attenuates Inflammation by Inducing Early M2 Macrophage Polarization in Skin Wound Healing.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 885, doi. 10.3390/ph16060885
- By:
- Publication type:
- Article
Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 884, doi. 10.3390/ph16060884
- By:
- Publication type:
- Article
Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson's Disease.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 883, doi. 10.3390/ph16060883
- By:
- Publication type:
- Article
Radiochemical and Biological Evaluation of 3p- C -NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 882, doi. 10.3390/ph16060882
- By:
- Publication type:
- Article
Phytochemicals as Antimicrobials: Prospecting Himalayan Medicinal Plants as Source of Alternate Medicine to Combat Antimicrobial Resistance.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 881, doi. 10.3390/ph16060881
- By:
- Publication type:
- Article
Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and β -Secretase 1: Next Generation for Alzheimer's Disease Treatment.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 880, doi. 10.3390/ph16060880
- By:
- Publication type:
- Article
Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure—Activity Relationship Studies.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 879, doi. 10.3390/ph16060879
- By:
- Publication type:
- Article
Annona muricata Leaf as an Anti-Cryptosporidial Agent: An In Silico Molecular Docking Analysis and In Vivo Studies.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 878, doi. 10.3390/ph16060878
- By:
- Publication type:
- Article
Chlorogenic Acid Induced Neuroblastoma Cells Differentiation via the ACAT1-TPK1-PDH Pathway.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 877, doi. 10.3390/ph16060877
- By:
- Publication type:
- Article
Enhancement of Scaffold In Vivo Biodegradability for Bone Regeneration Using P28 Peptide Formulations.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 876, doi. 10.3390/ph16060876
- By:
- Publication type:
- Article
Hyperhalophilic Diatom Extract Protects against Lead-Induced Oxidative Stress in Rats and Human HepG2 and HEK293 Cells.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 875, doi. 10.3390/ph16060875
- By:
- Publication type:
- Article
Mexican Native Black Bean Anthocyanin-Rich Extracts Modulate Biological Markers Associated with Inflammation.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 874, doi. 10.3390/ph16060874
- By:
- Publication type:
- Article
Recent Advances in the Green Synthesis of Active N -Heterocycles and Their Biological Activities.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 873, doi. 10.3390/ph16060873
- By:
- Publication type:
- Article
Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 872, doi. 10.3390/ph16060872
- By:
- Publication type:
- Article
Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 871, doi. 10.3390/ph16060871
- By:
- Publication type:
- Article
Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene Therapies.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 870, doi. 10.3390/ph16060870
- By:
- Publication type:
- Article
Gender Differences in Potentially Inappropriate Medication Use among Older Adults.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 869, doi. 10.3390/ph16060869
- By:
- Publication type:
- Article
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 868, doi. 10.3390/ph16060868
- By:
- Publication type:
- Article
Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 867, doi. 10.3390/ph16060867
- By:
- Publication type:
- Article
Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 866, doi. 10.3390/ph16060866
- By:
- Publication type:
- Article
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 865, doi. 10.3390/ph16060865
- By:
- Publication type:
- Article
Binary Polymeric Surfactant Mixtures for the Development of Novel Loteprednol Etabonate Nanomicellar Eyedrops.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 864, doi. 10.3390/ph16060864
- By:
- Publication type:
- Article
Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs).
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 863, doi. 10.3390/ph16060863
- By:
- Publication type:
- Article
Targeting Spike Glycoprotein S1 Mediated by NLRP3 Inflammasome Machinery and the Cytokine Releases in A549 Lung Epithelial Cells by Nanocurcumin.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 862, doi. 10.3390/ph16060862
- By:
- Publication type:
- Article
Study on the Intervention Mechanism of Cryptotanshinone on Human A2780 Ovarian Cancer Cell Line Using GC-MS-Based Cellular Metabolomics.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 861, doi. 10.3390/ph16060861
- By:
- Publication type:
- Article
Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 860, doi. 10.3390/ph16060860
- By:
- Publication type:
- Article
Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 859, doi. 10.3390/ph16060859
- By:
- Publication type:
- Article
Prediction of Cell Migration in MDA-MB 231 and MCF-7 Human Breast Cancer Cells Treated with Albizia Lebbeck Methanolic Extract Using Multilinear Regression and Artificial Intelligence-Based Models.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 858, doi. 10.3390/ph16060858
- By:
- Publication type:
- Article